Orbimed Advisors LLC Glaukos Corp Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$37.23 - $50.97 $45.1 Million - $61.7 Million	-1,211,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$28.78 - $46.83 $9.69 Million - $15.8 Million	-336,646 Reduced 21.75%	1,211,000 $46.5 Million
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $83.9 Million - $102 Million	1,547,646 New	1,547,646 $84.3 Million
Q1 2018 May 15, 2018	SELL	$26.05 - $34.5 $21.8 Million - $28.9 Million	-836,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $26.1 Million - $35.2 Million	836,500	836,500 $27.6 Million

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.